DE122007000052I1 - Verbindungen zur Photodekontamination von pathogenen Erregern im Blut - Google Patents

Verbindungen zur Photodekontamination von pathogenen Erregern im Blut

Info

Publication number
DE122007000052I1
DE122007000052I1 DE200712000052 DE122007000052C DE122007000052I1 DE 122007000052 I1 DE122007000052 I1 DE 122007000052I1 DE 200712000052 DE200712000052 DE 200712000052 DE 122007000052 C DE122007000052 C DE 122007000052C DE 122007000052 I1 DE122007000052 I1 DE 122007000052I1
Authority
DE
Germany
Prior art keywords
compounds
psoralen
blood
photodecontamination
pathogenic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE200712000052
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cerus Corp
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of DE122007000052I1 publication Critical patent/DE122007000052I1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
DE200712000052 1993-06-28 1994-06-24 Verbindungen zur Photodekontamination von pathogenen Erregern im Blut Pending DE122007000052I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/083,459 US5399719A (en) 1993-06-28 1993-06-28 Compounds for the photodecontamination of pathogens in blood
PCT/US1994/007185 WO1995000141A1 (en) 1993-06-28 1994-06-24 Compounds for the photodecontamination of pathogens in blood

Publications (1)

Publication Number Publication Date
DE122007000052I1 true DE122007000052I1 (de) 2007-11-08

Family

ID=22178486

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69434924T Expired - Lifetime DE69434924T2 (de) 1993-06-28 1994-06-24 Verbindungen zur photodekontamination von pathogenen erregern im blut
DE200712000052 Pending DE122007000052I1 (de) 1993-06-28 1994-06-24 Verbindungen zur Photodekontamination von pathogenen Erregern im Blut
DE69435250T Expired - Lifetime DE69435250D1 (de) 1993-06-28 1994-06-24 Verbindungen zur Photodekontamination von pathogenen Erregern im Blut

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69434924T Expired - Lifetime DE69434924T2 (de) 1993-06-28 1994-06-24 Verbindungen zur photodekontamination von pathogenen erregern im blut

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69435250T Expired - Lifetime DE69435250D1 (de) 1993-06-28 1994-06-24 Verbindungen zur Photodekontamination von pathogenen Erregern im Blut

Country Status (10)

Country Link
US (6) US5399719A (de)
EP (3) EP0707476B1 (de)
JP (1) JP4047374B2 (de)
AT (2) ATE353643T1 (de)
AU (1) AU699805B2 (de)
CA (1) CA2165984C (de)
DE (3) DE69434924T2 (de)
ES (2) ES2336574T3 (de)
HK (1) HK1083493A1 (de)
WO (1) WO1995000141A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4107396A (en) 1992-03-02 1996-06-06 Cerus Corporation Synthetic media for blood components
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
US5625079A (en) * 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US6004741A (en) * 1993-06-28 1999-12-21 Cerus Corporation Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
US5691132A (en) * 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
ES2337852T3 (es) * 1995-06-07 2010-04-29 Cerus Corporation Metodos y dispositivos para la eliminacion de psoralenos de productos sanguineos.
JP2009051846A (ja) * 1995-06-07 2009-03-12 Cerus Corp 血液製剤からソラレンを除去するための方法およびデバイス
WO1996039820A1 (en) * 1995-06-07 1996-12-19 Cerus Corporation Methods of inactivating leukocytes and inhibiting cytokine production in blood products
EP0773716A4 (de) * 1995-06-07 1999-08-04 Cerus Corp Behandlung von lösungen roter blutkörperchen mit antivralen wirkstoffen
AU6267596A (en) * 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
CA2250919C (en) * 1996-03-29 2008-05-13 Therakos, Inc. Photopheresis treatment of leukocytes
JP2000510003A (ja) * 1996-03-29 2000-08-08 セラコス・インコーポレーテツド 慢性ｈｃｖ感染のフォトフェレーシス処置
WO1997037654A1 (en) * 1996-04-10 1997-10-16 The Trustees Of The University Of Pennsylvania Use of photopheresis in the treatment of chronic infection by hepatitis c virus
US20020115585A1 (en) * 1996-06-07 2002-08-22 Hei Derek J. Method and devices for the removal of psoralens from blood products
US5841975A (en) * 1996-12-10 1998-11-24 The Regents Of The University Of California Method and apparatus for globally-accessible automated testing
US5968731A (en) * 1996-12-10 1999-10-19 The Regents Of The University Of California Apparatus for automated testing of biological specimens
US5925514A (en) * 1996-12-10 1999-07-20 The Regents Of The University Of California Apparatus for testing for infection by a retrovirus
US6514987B1 (en) * 1997-01-06 2003-02-04 Cerus Corporation Frangible compounds for pathogen inactivation
US6093725A (en) * 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
US5985914A (en) 1997-07-10 1999-11-16 Therakos, Inc. Treatment of inflammatory disorders of the bowel and urinary bladder
ES2210846T3 (es) * 1997-11-20 2004-07-01 Cerus Corporation Nuevos psoralenos para inactivar agentes patogenos.
US7611831B2 (en) * 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US20070099170A1 (en) * 1998-07-21 2007-05-03 Navigant Biotechnologies, Inc. Method for treatment and storage of blood and blood products using endogenous alloxazines and acetate
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US6255324B1 (en) 1998-11-25 2001-07-03 Ned D. Heindel Amino-and mercurio-substituted 4′,5'-dihydropsoralens and therapeutical uses thereof
DE69902821T2 (de) 1998-11-30 2003-01-09 Buckman Labor Inc 4'-substituierte-4',5'-dihydropsoralene und deren therapeutische verwendung
US7220747B2 (en) * 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US6576201B1 (en) 2000-01-28 2003-06-10 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
US6596230B1 (en) 2000-01-28 2003-07-22 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
US7985588B2 (en) * 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) * 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) * 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US7381976B2 (en) 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
US20030157073A1 (en) * 2001-11-29 2003-08-21 Peritt David L. Methods for pretreating a subject with apoptotic cells
US6936413B1 (en) * 2001-12-05 2005-08-30 Baxter International Inc. Methods and systems for preparing blood products
US7235392B2 (en) * 2001-12-07 2007-06-26 The Ohio State University Research Foundation Apoptotic EBV-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferative disorder
WO2003057129A1 (fr) * 2001-12-28 2003-07-17 Terumo Kabushiki Kaisha Systeme de sac sanguin et procede d'inactivation de micro-organismes pathogenes
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
EP1531823A4 (de) 2002-05-10 2007-07-18 Univ Ohio State Flavin n-oxide: neue krebsmittel und mittel zur beseitigung von erregern
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
JP4839209B2 (ja) * 2003-02-06 2011-12-21 アンザ セラピューティクス，インコーポレイテッド 改変された自由生活微生物、ワクチン組成物、およびそれらの使用方法
WO2004110481A2 (en) * 2003-02-06 2004-12-23 Cerus Corporation Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
US7026076B2 (en) * 2003-03-03 2006-04-11 Freescale Semiconductor, Inc. Method of patterning photoresist on a wafer using a reflective mask with a multi-layer ARC
US7534348B2 (en) * 2003-09-12 2009-05-19 Fenwal, Inc. Flow-through removal device and system using such device
AU2004237844B2 (en) 2003-12-23 2011-01-27 Therakos, Inc. Extracorporeal photopheresis in combination with anti-TNF treatment
NZ544247A (en) 2004-12-22 2007-06-29 Omj Ireland Ltd Phototherapy using psoralen derivatives and a UVB absorber
BRPI0618139A2 (pt) 2005-11-02 2011-08-16 Therakos Inc método de geração de células t com atividade reguladora, composição compreendendo uma população das referidas células e uso das mesmas
CN101484586A (zh) 2006-05-02 2009-07-15 特拉科斯有限公司 检测移植物抗宿主疾病易感性或移植相关死亡率的方法和试剂
DE102008051123A1 (de) * 2008-10-09 2010-04-15 Fresenius Kabi Deutschland Gmbh Beutel, Beutelset, Verfahren und Behandlungsvorrichtung zum Behandeln wenigstens einer Blutkomponente
WO2012033714A2 (en) 2010-09-07 2012-03-15 Sigma-Aldrich Co., Llc Cells for chromatin immunoprecipitation and methods for making
US20140127077A1 (en) 2012-11-05 2014-05-08 Gail Rock Device and method for sterilization of instruments and surfaces
EP3215139B1 (de) 2014-11-03 2020-08-19 Cerus Corporation Zusammensetzungen und verfahren für verbesserte car-t-zelltherapien
EA201890149A1 (ru) 2015-06-26 2018-07-31 Сирус Корпорейшн Композиции криопреципитатов и способы их получения
EP3325040A1 (de) * 2015-07-23 2018-05-30 Terumo BCT Biotechnologies, LLC Verringerung von durchflusspathogenen
CA3003097A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
CA3055203A1 (en) 2017-03-03 2018-09-07 Cerus Corporation Kits and methods for preparing pathogen-inactivated platelet compositions
AU2018338097B2 (en) 2017-09-20 2023-07-13 Cerus Corporation Compositions and methods for pathogen inactivation of platelets
KR20200115498A (ko) 2017-12-29 2020-10-07 세루스 코포레이션 생물학적 유체를 처리하기 위한 시스템 및 방법
EP3829668A2 (de) 2018-07-27 2021-06-09 Terumo BCT Biotechnologies, LLC Fluiddurchfluss
EP3991179A1 (de) 2019-06-28 2022-05-04 Cerus Corporation System und verfahren zur implementierung einer biologischen flüssigkeitsbehandlungsvorrichtung

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US451313A (en) * 1891-04-28 Gustav weinmann
US4169204A (en) * 1976-10-20 1979-09-25 Regents Of The University Of California Psoralens
US4196281A (en) * 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
US4124598A (en) * 1976-10-20 1978-11-07 Hoffmann-La Roche Inc. Psoralens
US4157723A (en) * 1977-10-19 1979-06-12 Baxter Travenol Laboratories, Inc. Method of forming a connection between two sealed conduits using radiant energy
US4265280A (en) * 1979-01-23 1981-05-05 Baxter Travenol Laboratories, Inc. Connector member for sealed conduits
US4216154A (en) * 1979-03-15 1980-08-05 Thomas C. Elder, Inc. Process for making α-loweralkylfurocoumarins
US4298614A (en) * 1979-09-10 1981-11-03 Thomas C. Elder, Inc. 5'-Aminoalkyl-4',4-dialkylpsoralens
US4269852A (en) * 1979-09-10 1981-05-26 Thomas C. Elder, Inc. 4'-Substituted-4,5',8-trialkylpsoralens
US4328239A (en) * 1979-09-10 1982-05-04 Elder Pharmaceuticals, Inc. 8-Aminoalkylpsoralens
US4370344A (en) * 1979-09-10 1983-01-25 Elder Pharmaceuticals, Inc. 5'-Aminoalkyl-4'-alkylpsoralens
US4269851A (en) * 1979-09-10 1981-05-26 Thomas C. Elder, Inc. 8-Aminoalkyl-4-alkylpsoralens
US4235781A (en) * 1979-09-20 1980-11-25 Thomas C. Elder, Inc. 6 Or 8 Haloallyl substituted 7-hydroxycoumarins
US4321919A (en) 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4294847A (en) * 1980-07-29 1981-10-13 Thomas C. Elder, Inc. 8-Aminoalkyl-4-alkylisopsoralens
US4294822A (en) * 1980-07-29 1981-10-13 Thomas C. Elder, Inc. 5-Aminoalkyl-4,4,8-trialkylpsoralens
US4279922A (en) * 1980-07-29 1981-07-21 Thomas C. Elder, Inc. Photosensitizing benzofuranacrylics
US4412835A (en) * 1982-07-06 1983-11-01 E. I. Du Pont De Nemours & Company Sterile docking process, apparatus and system
US4613322A (en) 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
ATE59145T1 (de) * 1983-05-02 1991-01-15 Diamond Scient Co Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen.
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4599303A (en) 1983-12-12 1986-07-08 Hri Associates, Inc. Nucleic acid hybridization assay employing probes crosslinkable to target sequences
US4705886A (en) * 1984-03-21 1987-11-10 Cetus Corporation Precursor to nucleic acid probe
US4582789A (en) * 1984-03-21 1986-04-15 Cetus Corporation Process for labeling nucleic acids using psoralen derivatives
US4751313A (en) * 1984-03-21 1988-06-14 Cetus Corporation Precursor to nucleic acid probe
US4803297A (en) * 1984-03-21 1989-02-07 Cetus Corporation Carbamic acid ester useful for preparing a nucleic acid probe
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
US4754065A (en) * 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US5026840A (en) * 1985-01-10 1991-06-25 Molecular Diagnostics, Inc. Photochemical nucleic acid-labeling reagent having a polyalklamine spacer
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4822731A (en) * 1986-01-09 1989-04-18 Cetus Corporation Process for labeling single-stranded nucleic acids and hybridizaiton probes
US4950770A (en) * 1987-06-16 1990-08-21 Elder Pharmaceuticals, Inc. Psoralens aminomethylation
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
WO1988010272A1 (en) 1987-06-26 1988-12-29 Garth Alexander Nicholson Method of preserving a body fluid sample, prior to assay for hiv (aids) infection
DE3804243A1 (de) * 1988-02-11 1989-08-24 Max Planck Gesellschaft Teils einzel- und teils doppelstraengige nukleinsaeuresonde und verfahren zu ihrer herstellung
GB8807380D0 (en) 1988-03-29 1988-05-05 Gunn A Blood processing apparatus
US5571666A (en) 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
US5356929A (en) 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5041078A (en) 1989-03-06 1991-08-20 Baylor Research Foundation, A Nonprofit Corporation Of The State Of Texas Photodynamic viral deactivation with sapphyrins
DE3928900A1 (de) * 1989-08-31 1991-03-07 Europ Lab Molekularbiolog Neue nucleotidderivate, ihre herstellung und ihre verwendung
DE3930510A1 (de) 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US5556958A (en) 1989-10-26 1996-09-17 Steritech, Inc. Inactivation of pathogens in clinical samples
US5184020A (en) 1989-10-26 1993-02-02 Hearst David P Device and method for photoactivation
US5049578A (en) * 1990-03-09 1991-09-17 E. R. Squibb & Sons, Inc. 1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
JP3182145B2 (ja) * 1990-04-16 2001-07-03 日本赤十字社 血小板保存液
ZA912842B (en) 1990-04-16 1992-03-25 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
IL99069A (en) 1990-08-09 1998-08-16 Genta Inc Methyphosphonate oligonucleotides associated with psoralen
US5376524A (en) * 1991-04-01 1994-12-27 Thomas Jefferson University Platelet storage medium containing acetate and phosphate
CA2060804C (en) 1992-02-06 1999-10-05 Luis P. Cardenas Cigarette-lighter-extinguisher-cigarette holder with or without butt ejector
US5709991A (en) 1992-03-02 1998-01-20 Cerus Corporation Proralen inactivation of microorganisms and psoralen removal
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
AU6402494A (en) * 1993-03-11 1994-09-26 Steritech, Inc. Decontaminating clinical samples
US5593823A (en) * 1993-06-28 1997-01-14 Cerus Corporation Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
US5871900A (en) 1993-06-28 1999-02-16 Cerus Corporation Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
US6004741A (en) 1993-06-28 1999-12-21 Cerus Corporation Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6004742A (en) 1993-06-28 1999-12-21 Cerus Corporation Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
US5762867A (en) 1994-09-01 1998-06-09 Baxter International Inc. Apparatus and method for activating photoactive agents

Also Published As

Publication number Publication date
DE69434924T2 (de) 2007-11-22
US5585503A (en) 1996-12-17
JP4047374B2 (ja) 2008-02-13
US5399719A (en) 1995-03-21
ES2336574T3 (es) 2010-04-14
AU699805B2 (en) 1998-12-17
EP1776952A2 (de) 2007-04-25
HK1083493A1 (en) 2006-07-07
EP0707476B1 (de) 2007-02-14
EP1584622A2 (de) 2005-10-12
DE69435250D1 (de) 2009-12-24
EP0707476A4 (de) 1998-12-23
US5578736A (en) 1996-11-26
ATE448233T1 (de) 2009-11-15
US5654443A (en) 1997-08-05
JPH08512032A (ja) 1996-12-17
WO1995000141A1 (en) 1995-01-05
US6503699B1 (en) 2003-01-07
EP1584622A3 (de) 2007-10-17
DE69434924D1 (de) 2007-03-29
AU7251194A (en) 1995-01-17
ES2282991T3 (es) 2007-10-16
US5972593A (en) 1999-10-26
EP0707476A1 (de) 1996-04-24
EP1776952A3 (de) 2007-05-02
EP1584622B1 (de) 2009-11-11
CA2165984A1 (en) 1995-01-05
CA2165984C (en) 2004-01-20
ATE353643T1 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
DE69435250D1 (de) Verbindungen zur Photodekontamination von pathogenen Erregern im Blut
DE69819360D1 (de) Neue psoralene zur inaktivierung von pathogenen
DE3887875T2 (de) Verfahren zur vorbeugung einer von blutplättchen abhängigen gefässthrombose.
DE122008000026I2 (de) Verfahren zur inaktivierung von viren in blut und blutprodukten
DE69027187T2 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
IL143747A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
DE69201235D1 (de) Behälter zur bestrahlung von blutprodukten.
IE960853L (en) Vascular anticoagulant proteins
DE69029528T2 (de) Verwendung von funkionellen Derivaten des Interzellulär-Adhäsions-Moleküls ICAM-1 in einer Antivirus-Therapie
DE59007785D1 (de) Pasteurisiertes, gereinigtes von Willebrand-Faktor-Konzentrat und Verfahren zu seiner Herstellung.
DE69413120D1 (de) Verwendung von L-Carnitin und Alkanoyl L-Carnitine zum Bewahren von Transfusionsblut, und sie enthaltenden Stabilisierungslösungen
GR3026253T3 (en) Process of preparation of a virus-free thrombin concentrate.
ATE194648T1 (de) Verfahren zur inaktivierung von viren in präparationen von proteinen
CA2415063A1 (en) Photodynamic treatment and uv-b irradiation of a platelet suspension
DE69117920T2 (de) Zusammensetzung zur stabilisierung von blutplasma im laufe der pasteurisation
ATE127118T1 (de) 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
UA31369A (uk) Спосіб покращання кровотоку пілородуоденальної зони